2011
DOI: 10.1016/j.expneurol.2011.03.017
|View full text |Cite
|
Sign up to set email alerts
|

Dose and duration of nerve growth factor (NGF) administration determine the extent of behavioral recovery following peripheral nerve injury in the rat

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
88
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 113 publications
(92 citation statements)
references
References 57 publications
4
88
0
Order By: Relevance
“…NTFs have been long studied for their positive effects on nerve regeneration, including their ability to promote neuronal survival, to increase axonal outgrowth and to improve target reinnervation. Different NTFs have been tested in vitro and in vivo to improve 4 peripheral nerve regeneration, such as nerve growth factor (NGF) (Kemp et al, 2011;Lee et al, 2003), brain-derived neurotrophic factor (BDNF) (Vögelin et al, 2006), neurotrophin-3 (NT-3) (Sternel et al, 1997), glial cell-derived neurotrophic factor (GDNF) (Moore et al, 2010), fibroblast growth factors (FGF1, FGF2) (Midha et al, 2003;Allodi et al, 2013) or insulin like growth factors (IGF1, IGF2) (Ishi et al, 1993;Kanje et al, 1989).…”
Section: Introductionmentioning
confidence: 99%
“…NTFs have been long studied for their positive effects on nerve regeneration, including their ability to promote neuronal survival, to increase axonal outgrowth and to improve target reinnervation. Different NTFs have been tested in vitro and in vivo to improve 4 peripheral nerve regeneration, such as nerve growth factor (NGF) (Kemp et al, 2011;Lee et al, 2003), brain-derived neurotrophic factor (BDNF) (Vögelin et al, 2006), neurotrophin-3 (NT-3) (Sternel et al, 1997), glial cell-derived neurotrophic factor (GDNF) (Moore et al, 2010), fibroblast growth factors (FGF1, FGF2) (Midha et al, 2003;Allodi et al, 2013) or insulin like growth factors (IGF1, IGF2) (Ishi et al, 1993;Kanje et al, 1989).…”
Section: Introductionmentioning
confidence: 99%
“…Present time points for the regeneration analysis were based on our earlier observations of peripheral nerve regeneration after transection injury. 19,20,47 In sharp contrast to the medium injection group, animals that received cell therapy showed by Week 10 clear signs of return to the normalgesic state according to a standard Hargreaves plantar test. The SKP-SC group showed maximum recovery potential, which was, however, closely followed by the nSC group.…”
Section: Discussionmentioning
confidence: 91%
“…All animals received an immediate entubulation repair within a silicon tube, inner diameter 1.5 mm, secured with 9-0 Prolene microsutures at each end, leaving a 5-mm gap between the proximal and distal stumps, using previously reported techniques. 19,38 Immediately following repair, 10 ml of nSCs (n = 6) or SKP-SCs (n = 5) or carrier medium (n = 6) was injected using a 10-ml Hamilton syringe with a 30-gauge needle into the segment of transected sciatic nerve immediately distal to the graft, giving a total of 1 × 10 6 cells. Schwann cells were labeled 20 minutes prior to injection with CellTracker CM-DiI (Invitrogen) according to the manufacturer's guidelines.…”
Section: Surgical Proceduresmentioning
confidence: 99%
“…In addition, augmentation of NGF enhances cholinergic neuronal markers and blockade of endogenous NGF impairs the retention of the spatial memory 35 . Administration of NGF is a significant determinant for the recovery of neural behavior 36 . Furthermore, mature NGF regulates neuronal cell survival via the binding of TrkaA and p75NTR receptors, and preform NGF promotes neuronal apoptosis also via the binding of p75NTR 37,38 .…”
Section: ■ Discussionmentioning
confidence: 99%